Alper Kahvecioglu MD Profile
Alper Kahvecioglu MD

@kahvecioglu_a

Followers
222
Following
417
Media
13
Statuses
107

Radiation Oncologist - Hacettepe University - Views my own.

Ankara, Türkiye
Joined January 2024
Don't wanna be here? Send us removal request.
@kahvecioglu_a
Alper Kahvecioglu MD
2 days
RT @troddernegi: 🎯 Upcoming Webinar Alert !. We are pleased to invite you to a free webinar organized by The Radiosurgery Society ☢️ . 📅 Th….
0
3
0
@kahvecioglu_a
Alper Kahvecioglu MD
2 days
RT @troddernegi: 📍 The results of an anticipated study (NRG-CC003). In SCLC 🫁 , hippocampal avoidance during PCI preserves intracranial con….
Tweet card summary image
ascopubs.org
PURPOSEHippocampal avoidance (HA) during therapeutic whole-brain radiotherapy reduces the risk of neurocognitive function (NCF) toxicity in patients with brain metastasis. This trial hypothesized...
0
1
0
@kahvecioglu_a
Alper Kahvecioglu MD
3 days
RT @StasLazarev: ⚡️New glioblastoma study: . NRG BN007 (Phase II, n=159) - newly diagnosed MGMT-unmethylated glioblastoma, KPS ≥70, RT+Ipi+….
0
11
0
@kahvecioglu_a
Alper Kahvecioglu MD
7 days
RT @StasLazarev: ⚡️Today's FDA Accelerated Approval of ONC201 for H3 K27M-Mutant Diffuse Midline Glioma is TROUBLING!. ONC201 is celebrated….
0
12
0
@kahvecioglu_a
Alper Kahvecioglu MD
8 days
Bicalutamide may be history, but we still need biomarkers and clinical tools BEYOND PSA to guide antiandrogen use with salvage ☢️ . 👉🏻 Precision matters 🧬.
0
0
2
@kahvecioglu_a
Alper Kahvecioglu MD
9 days
Long-term results of RTOG 9601 . 👉🏻 Nearly 20 years of follow-up . 💥 Salvage RT + 2 years of bicalutamide = ↓ distant mets 👇🏻. •GS 8–10: ✅ p<0.001.•Positive margins: ✅ p=0.001.•PSA >1.5: ✅ p=0.004.•PSA 0.7–1.5: ❌ p=0.07 (NS). @IJROBP.
Tweet card summary image
redjournal.org
Salvage radiation therapy (RT) is used in men with prostate cancer (PC) recurrence following radical prostatectomy (RP) signaled by a persistent or delayed elevation in PSA. It was previously...
1
17
26
@kahvecioglu_a
Alper Kahvecioglu MD
17 days
RT @ESGO_society: Just published in The Lancet! ‼️🗞️ ESGO-ESTRO-ESP Guidelines for the Management of Patients with Endometrial Carcinoma:….
0
40
0
@kahvecioglu_a
Alper Kahvecioglu MD
20 days
RT @crispinhiley: No role for mediastinal LN dissection in clinical stage T1N0M0 GGO-dominant invasive lung adeno, defined by consolidatio….
0
13
0
@kahvecioglu_a
Alper Kahvecioglu MD
22 days
RT @banu_atalar: No PCI and SRS for limited mets in SCLC under close follow-up — I believe this is the new standard. I’ve been using this a….
Tweet card summary image
ascopubs.org
PURPOSEStereotactic radiation (SRS/SRT) as opposed to whole-brain radiation (WBRT) represents the standard of care for patients with a limited number of brain metastases given the relatively favora...
0
3
0
@kahvecioglu_a
Alper Kahvecioglu MD
26 days
RT @DrYukselUrun: In high-risk prostate cancer, radiotherapy plus ADT significantly reduces the risk of distant metastasis compared to surg….
0
55
0
@kahvecioglu_a
Alper Kahvecioglu MD
1 month
RT @ASTRO_org: Read a new #RedJournal article from @mtugceyilmaz et al on 15 Years of Experience with Stereotactic Body Radiotherapy for Re….
0
8
0
@kahvecioglu_a
Alper Kahvecioglu MD
1 month
RT @TheLancetOncol: Intensity-modulated moderately hypofractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer….
0
17
0
@kahvecioglu_a
Alper Kahvecioglu MD
2 months
RT @mtugceyilmaz: 🚨 Just out in Red Journal! . We analyzed our 191-patient H&N reirradiation cohort, with a specific focus on toxicity and….
0
29
0
@kahvecioglu_a
Alper Kahvecioglu MD
2 months
🆕 Just published in @gynoncjnls !. Our new study explores prognostic heterogeneity in FIGO 2023 stage IIC endometrial cancer. 🌊 One sea, different depths 🌊. 👉🏻
Tweet media one
0
1
9
@kahvecioglu_a
Alper Kahvecioglu MD
2 months
💥 Just published!. Does Anterior Commissure Involvement Matter for Early‐Stage Glottic Cancer in the Intensity‐Modulated Radiotherapy Era?. ✅ Our latest study is now available online! . 👉🏻 @mtugceyilmaz @SepideMoh . #Radiotherapy #GlotticCancer #IMRT.
onlinelibrary.wiley.com
Objective Anterior commissure involvement (ACI) is a negative prognostic factor for local control (LC) in early-stage glottic cancer (ESGC) treated with radiotherapy (RT). However, its impact in...
0
2
13
@kahvecioglu_a
Alper Kahvecioglu MD
2 months
👉🏻A case fitting NSABP B‑51 criteria at St. Gallen 2025 . Expert opinions all over the place 💥. Consensus? Far from it…
Tweet media one
0
0
2
@kahvecioglu_a
Alper Kahvecioglu MD
2 months
👉🏻 NSABP B‑51 supports omitting RNI in ypN0 patients after NAC ✅. 👉🏻However, the low event rate, limited follow-up, and selected cohort warrant extreme caution - particularly in high-risk subgroups ⁉️. 👉🏻 Long term follow-up is mandatory before broad adoption ⚠️.
@changjeesuk1
JeeSuk Chang
2 months
#Poll Based on NSABP-B51, what would you do in clinical practice?. 1. I’ll wait for more evidence. 2. I’ll apply it right away. 3. Case by case. Also curious—how much variation is there in assessing pCR between pathologists?There can be reliability issue of pCR 🤔.
1
1
14
@kahvecioglu_a
Alper Kahvecioglu MD
2 months
RT @mtugceyilmaz: 🚀 New from our clinic!. "Gyroscopic Radiosurgery-Based Lattice Therapy for intracranial tumors" now published!. 📝 Read ou….
cureus.com
Lattice radiotherapy (LRT), a modern form of spatially fractionated radiation therapy, introduces a novel therapeutic strategy by delivering high-dose vertices interspersed within the gross tumo...
0
3
0
@kahvecioglu_a
Alper Kahvecioglu MD
2 months
RT @SimonLo21054188: Stereotactic Ablative Body Radiotherapy for Oligoprogressive Estrogen Receptor–Positive Breast Cancer (TROG 20.03 AVAT….
Tweet card summary image
ascopubs.org
PURPOSEAVATAR (trial registration: ACTRN 12620001212943) is a multicenter phase II single-arm trial to evaluate whether stereotactic ablative body radiotherapy (SABR) for oligoprogressive estrogen...
0
24
0